Daily Anesthesiology Research Analysis
Analyzed 37 papers and selected 3 impactful papers.
Summary
Today’s most impactful anesthesiology research spans practice guidelines, perioperative pharmacology, and prognostic risk stratification. New French national guidelines (GRADE-based) standardize emergency adult intubation outside the OR/ICU, a high-risk setting. A randomized trial shows ciprofol–nalbuphine reduces cardiopulmonary adverse events during painless GI endoscopy versus propofol–nalbuphine, and a large cohort identifies postoperative RDW (≥15) as a simple predictor of 30-day and 1-year mortality in surgical ICU patients.
Research Themes
- Emergency airway management outside the OR/ICU
- Sedation pharmacology and safety in endoscopy
- Perioperative prognostication using hematologic indices
Selected Articles
1. Guidelines 2024: Emergency intubation of an adult outside the operating room and intensive care unit.
A multi-society, GRADE-based guideline process generated 32 recommendations for adult emergency intubation outside the OR/ICU, with strong consensus after iterative scoring. Five recommendations were supported by high-level evidence, 12 by low-level evidence, and 15 were expert opinions.
Impact: Emergency airway management outside controlled environments is high risk; standardized, evidence-graded recommendations can immediately harmonize practice and improve safety.
Clinical Implications: Adoption of GRADE-based recommendations can structure preoxygenation, preparation, team roles, and first-pass success strategies for out-of-OR intubations, while highlighting areas needing local protocols and audit.
Key Findings
- 32 recommendations were produced for adult emergency intubation outside the OR/ICU using GRADE.
- Evidence strength: 5 high-level (GRADE 1), 12 low-level (GRADE 2), and 15 expert opinions; 4 questions had no supporting literature.
- Strong consensus was achieved after four rounds of scoring and amendments, with COI management and no industry funding.
Methodological Strengths
- GRADE methodology with PICO-structured questions and comprehensive literature synthesis
- Transparent COI policy and multi-society expert consensus with iterative Delphi-like rounds
Limitations
- Many recommendations rely on low-quality evidence or expert opinion due to limited studies in this setting
- Generalizability may require adaptation to local systems and resources
Future Directions: Prospective studies and registries on out-of-OR/ICU intubations are needed to upgrade evidence quality and validate key process and outcome measures.
OBJECTIVE: To provide guidelines for guidelines on adult patient intubation in emergency settings outside the operating room and intensive care unit. DESIGN: A consensus committee of 24 experts from the French Society of Anaesthesia and Intensive Care Medicine (Société Française d'Anesthésie et de Réanimation, SFAR) and the French Society of Emergency Medicine (Société Française de Médecine d'Urgence, SFMU) was convened. A formal conflict-of-interest (COI) policy was developed at the beginning of the process and enforced throughout. The entire guideline construction process was conducted independently of any industrial funding (i.e., pharmaceutical, medical devices). The authors were required to follow the rules of the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system to guide the assessment of the quality of evidence. The potential drawbacks of making strong recommendations in the presence of low-quality evidence were emphasised. METHODS: The aim of these expert panel guidelines is to evaluate adult patient intubation in emergency settings outside the operating room and intensive care unit. The experts studied questions within 5 domains. Each question was formulated according to the PICO (Patients Intervention Comparison Outcome) model, and the evidence profiles were produced. An extensive literature review and recommendations were carried out and analysed according to the GRADE® methodology. RESULTS: The experts' synthesis and the application of the GRADE® method yielded 32 recommendations for adult patient intubation in emergency settings outside the operating room and intensive care unit. Among the formalised recommendations, 5 have high levels of evidence (GRADE 1), and 12 have low levels of evidence (GRADE 2). For 15 recommendations, the GRADE method could not be applied, resulting in expert opinions. 4 questions did not find any response in the literature. After 4 rounds of scoring and amendment, strong agreement was reached for all the recommendations. CONCLUSIONS: There was strong agreement among experts for 36 recommendations to improve practices for adult patient intubation in emergency settings outside the operating room and intensive care unit.
2. Comparison of Ciprofol-Nalbuphine and Propofol-Nalbuphine Sedation During Painless Gastrointestinal Endoscopy: A Randomized Controlled Trial.
In a single-center RCT of 128 patients undergoing painless GI endoscopy, ciprofol–nalbuphine reduced induction cardiopulmonary adverse events versus propofol–nalbuphine (4.8% vs 18.7; P=0.028) and lowered procedural complications such as injection pain, cough reflex, and body movement. Sedative efficacy was equivalent with improved recovery characteristics.
Impact: Demonstrates a potentially safer sedative regimen by leveraging a newer hypnotic (ciprofol) with favorable hemodynamic/respiratory stability in a common procedural setting.
Clinical Implications: Ciprofol–nalbuphine may be considered as an alternative to propofol–nalbuphine for GI endoscopy, particularly in patients at risk for hypotension or hypoxemia; broader multicenter validation is needed before widespread adoption.
Key Findings
- Ciprofol–nalbuphine reduced induction cardiopulmonary adverse events vs propofol–nalbuphine (4.8% vs 18.7%; P=0.028).
- Procedural complications (injection pain, cough reflex, body movement) were lower with ciprofol (P=0.011).
- Sedative efficacy was equivalent with improved recovery characteristics in the ciprofol group.
Methodological Strengths
- Randomized allocation with predefined primary endpoint
- Standardized dosing and co-analgesic (nalbuphine) across groups
Limitations
- Single-center design and modest sample size limit generalizability
- Blinding and allocation concealment details not reported; short-term outcomes only
Future Directions: Conduct multicenter, adequately powered RCTs including high-risk subgroups and standardized recovery metrics; assess cost-effectiveness and patient-reported outcomes.
BACKGROUND Although propofol is widely used for painless gastrointestinal endoscopy, cardiopulmonary adverse events associated with its use are still common. Ciprofol is a novel intravenous anesthetic with respiratory and hemodynamic stability. The aim of this study was to evaluate the benefits of ciprofol combined with nalbuphine for painless gastrointestinal endoscopy in reducing the occurrence of cardiopulmonary adverse events and improving postendoscopic recovery. MATERIAL AND METHODS In this single-center randomized study, a total of 128 patients undergoing painless gastrointestinal endoscopy were randomly assigned to 2 groups: propofol combined with nalbuphine or ciprofol combined with nalbuphine. All patients received 0.15 mg/kg nalbuphine intravenously before the study drugs were administered. The propofol group received a bolus of 2 mg/kg propofol intravenously, whereas the ciprofol group received a bolus of 0.4 mg/kg ciprofol intravenously. The primary endpoint was the incidence of intraprocedural cardiopulmonary adverse events (hypotension, bradycardia, and hypoxemia). RESULTS The ciprofol group demonstrated a significantly lower rate of cardiopulmonary adverse events during induction, compared with the propofol cohort (4.8% vs 18.7%; P=0.028). Furthermore, ciprofol administration was associated with lower procedural complications, including injection pain, cough reflex, and body movement (P=0.011). CONCLUSIONS Ciprofol-nalbuphine sedation demonstrates a superior safety profile, with fewer hemodynamic and respiratory perturbations and improved procedural tolerance, compared with propofol-nalbuphine in painless gastrointestinal endoscopy, while maintaining equivalent sedative efficacy and enhanced recovery characteristics.
3. A single postoperative red cell distribution width measurement predicts short- and long-term mortality in surgical patients.
In a 2-year retrospective cohort of 2312 surgical ICU patients, a single postoperative RDW measured within 2 hours predicted mortality at 30 days and 1 year. RDW ≥15 tripled the hazard for both 30-day and 1-year mortality, and adding RDW improved model fit; lactate and pre-existing lung disease modified RDW’s predictive value.
Impact: RDW is inexpensive and widely available; integrating it into postoperative risk models can enhance early risk stratification without additional resource burden.
Clinical Implications: Consider using a postoperative RDW threshold (≥15) to flag high-risk surgical ICU patients for intensified monitoring, optimization of comorbidities, and early follow-up planning.
Key Findings
- Each unit increase in RDW was associated with higher 30-day (HR 1.169) and 1-year mortality (HR 1.153).
- RDW ≥15 tripled 30-day (HR 3.247) and 1-year mortality risk (HR 3.278).
- Adding RDW improved multivariable model fit (AIC), with effect modification by lactate and pre-existing lung disease.
Methodological Strengths
- Large sample size with multivariable adjustment and interaction analyses
- Objective, readily available biomarker measured in a standardized window (within 2 hours post-op)
Limitations
- Retrospective single-center design with potential residual confounding
- Single postoperative RDW measurement; causality cannot be inferred
Future Directions: Prospective, multicenter validation and interventional studies to test whether RDW-guided care pathways improve outcomes; mechanistic studies to elucidate RDW drivers postoperatively.
BACKGROUND: The red cell distribution width (RDW) measures erythrocyte size variability and is linked to increased mortality in various diseases, including cardiovascular, kidney, and liver conditions. In critically ill patients, particularly those with sepsis, RDW is a prognostic marker. While its role in cardiac surgery patients is well established, its value in surgical patients is less well explored. This study investigates whether a single postoperative RDW measurement predicts short- and long-term mortality surgical intensive care unit (ICU) patients. METHODS: This retrospective cohort study analyzed data from 2312 surgery patients admitted to a surgical ICU over 2 years. The RDW was measured within 2 h of surgery and analyzed as a continuous and binary variable (threshold 15). Mortality at 30 days and 1 year was assessed using univariable and multivariable logistic regression and Cox regression models, adjusting for factors like the simplified acute physiology score 3 (SAPS3), lactate levels, age, sex, and comorbidities. Interaction analyses evaluated the impact of cofactor on RDW's mortality prediction. RESULTS: Of 2312 patients, 1687 (73.0%) had RDW < 15 and 625 (27.0%) had RDW ≥ 15. The RDW ≥ 15 patients were older (p < 0.001), had higher SAPS3 (p < 0.001), and more comorbidities. Elevated RDW was independently associated with increased 30-day and 1-year mortality. In univariable analysis, each unit increase in RDW was linked to higher 30-day mortality (HR 1.169, 95% CI 1.110-1.230; p < 0.001) and 1-year mortality (HR 1.153, 95% CI 1.122-1.186; p < 0.001). Moreover, RDW ≥ 15 significantly increased the risk of 30-day (HR [Hazard Ratio] 3.247, 95% CI 2.352-4.482; p < 0.001) and 1-year mortality (HR 3.278, 95% CI 2.654-4.048; p < 0.001). Interaction analyses showed that lactate levels and pre-existing lung diseases influenced RDW's mortality prediction. Including RDW in multivariable models improved predictive accuracy, as indicated by the Akaike information criterion. CONCLUSION: Postoperative RDW is a reliable and cost-effective marker for predicting short- and long-term mortality in surgical patients. An RDW threshold of 15 identifies high-risk patients who may benefit from targeted follow-up, thus potentially improving outcomes. In summary, RDW enhances postoperative risk stratification and management.